The future of rotavirus vaccines: a major setback leads to new opportunities.
Glass
Roger I
RI
Viral Gastroenteritis Section, Respiratory and Enteric Viruses Branch, Division of Viral and Rickettsial Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. rglass@cdc.gov
Bresee
Joseph S
JS
Parashar
Umesh D
UD
Jiang
Baoming
B
Gentsch
Jon
J
D000284:Administration, Oral; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003906:Developing Countries; D003968:Diarrhea, Infantile / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology; D017277:Drug Approval; D006801:Humans; D007223:Infant; D007443:Intussusception / Q000209:etiology*; D012307:Risk Factors; D012400:Rotavirus Infections / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D022243:Rotavirus Vaccines / Q000009:adverse effects*; D014611:Vaccination / Q000009:adverse effects; D014613:Vaccines, Attenuated / Q000009:adverse effects
D022243:Rotavirus Vaccines; D014613:Vaccines, Attenuated